TFS Capital’s Pfizer PFE Stock Holding History

TFS Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-13,542	Closed	-$413K	–	1304
2014 Q1	$413K	Buy	+13,542	New	+$404K	0.03%	831

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

TFS Capital's PFE Position: Q2 2014 in Review

TFS Capital sold out of Pfizer (PFE) in Q2 2014, closing a stake of 13,542 shares — an estimated $413K sold.

TFS Capital first reported a position in PFE in Q1 2014 and held it in 1 quarter. The position peaked at $413K in Q1 2014. 1,746 funds tracked by Wall St. Rank hold PFE as of Q2 2014.

TFS Capital reported no remaining Pfizer position as of Q2 2014 after selling out during the quarter.
TFS Capital sold 13,542 Pfizer shares in Q2 2014, an estimated $413K.
TFS Capital first reported a position in Pfizer in Q1 2014 and held it in 1 quarter.
TFS Capital's Pfizer position peaked at $413K in Q1 2014.
1,746 funds tracked by Wall St. Rank held Pfizer as of Q2 2014.

Based on TFS Capital's 13F filing for Q2 2014, filed 21 Jul 2014.